Janssen vaccine / Johnson & Johnson
Date: February 27, 2021Author: harold jitschak bueno de mesquita0 Comments— Edit
One single dose
Under the agreement, Johnson & Johnson will manufacture 100 million doses of its coronavirus vaccine in the U.S. for $1 billion as soon as it clears the FDA’s emergency use approval. That averages about $10 per dose, which is the cheapest among vaccine candidates on BARDA’s purchase list.
From what I’ve read and what the FDA has published, the Johnson vaccine has a 60% success rate. Why would anyone want to take this vaccine??
Yehudit
LikeLike
please see the videos and ALL that is published and see my remarks about Pfizer……….you
may still disagree…………we hope Janssen will not want to sell us a yearly vaccine for the rest of our life [certainly not our children]
LikeLike